Table 4.
Multivariate Cox regression analysis for postoperative progression.
| Variables | Recurrence multivariate analysis | Metastasis multivariate analysis | Death multivariate analysis | |||
|---|---|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
| Post-op CA19-9 (u/ml):≤ 37 vs>37 | 7.11 (1.23-40.90) | 0.028* | NA. | NA. | ||
| T stage: T1-T2 vs T3 | 4.37 (0.75-25.55) | 0.10 | NA. | NA. | ||
| Lymph node invasion: N0 vs N1-N2 | NA. | 5.01 (1.28-19.54) | 0.020* | 2.531 (0.78-8.18) | 0.12 | |
| Differentiation: High vs Middle and low | NA. | 0.67 (0.20-2.27) | 0.52 | NA. | ||
| PoV E>M H-CTC (per 5ml): <3 vs ≥ 3 | 1.22 (0.11-13.08) | 0.870 | NA. | NA. | ||
| PoV T-CTC (per 5ml): <14 vs ≥ 14 | 3.84 (0.48-30.28) | 0.202 | NA. | NA. | ||
| PoV E-CTC (per 5ml): <5 vs ≥ 5 | 0.58 (0.094-3.64) | 0.56 | NA. | NA. | ||
| PoV M-CTC (per 5ml): <1 vs ≥ 1 | NA. | 6.795 (1.89-24.39) | 0.003* | 3.100 (1.03-9.27) | 0.043* | |
NA, no application.
Bold values indicate that the results were statistically significant.